Monday, 17 March 2014

Adding Up The Overrule


Since The Overrule's inception 6 years ago through syndication here's a breakdown of the numbers and profits subscribers have tasted. The Overrule took a year off in 2012 and returned in 2013 free of syndication to the place we are today tailored to the needs of individual subscribers.

In total from inception up to and including last week's results against general best price.

Bets: 605
Stake: 1592.00 points
Profit: +232.60 points
Return on Investment (ROI): 14.61%

Generally an ROI of 5% over a season in tennis is considered a desirable return but The Overrule is returning over double that return over a number of years with consistency each year. A £100 per point bettor (The Overrule's maximum advised stake on a single selection is 5 points or £500 and on average 2.63 points or £263) has profited to the tune of £23,260 since The Overrule's inception.

Since 2013 The Overrule has also been tracking and advising selections with Pinnacle users in mind for those bettors who have been restricted at traditional bookmakers for past success. During that time here are the numbers on how The Overrule has fared on match-bets against Pinnacle since the 2013 season up to and including last week's results.

Bets 76
Stake 181.00 points
Profit: +41.66 points
ROI: 23.02%

A £100 per point bettor has profited to the tune of £4166 on match-bets alone against Pinnacle using The Overrule's selections since the start of 2013. And this season those portfolio of match-bets will increase for 2014 season subscribers.

For full details of how The Overrule performed in 2013, check out the season review.

How The Overrule has performed in 2014 against general best price and Pinnacle.

The Overrule has subscribers from the UK, US, Canada and Australia and is one of few services that offers a money back guarantee and a regular personalised service on a daily basis throughout the season. Details on how to join The Overrule from early April will be available soon or get in touch at theoverrule@gmail.com for further information.

No comments:

Post a Comment